TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
CLPT

Clearpoint Neuro Inc

Healthcare · Medical Devices

15.00$ -5.2% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

Clearpoint Neuro Inc (CLPT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -24 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow CLPT
Line item 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-7.7 -6.2 -7.4 -7.8 -7.3 -8.6 -5.8 -6.0 -4.6 -2.8 -7.8 -13 -16 -14 -9.0 -24
0.3 0.4 0.4 0.4 0.4 0.2 0.2 0.1 0.1 0.3 0.6 0.7 0.8 1.5 1.9 1.0
0.2 1.0 2.0 1.5 0.9 1.7 1.0 1.2 1.2 0.8 1.1 2.1 4.1 6.1 6.9 8.2
– – – – – – 1.0 1.7 1.2 0.8 0.2 2.6 4.0 – – –
-0.2 -0.6 -6.4 -2.1 1.2 -1.2 0.7 -1.1 -0.4 0.9 -2.7 -1.7 -4.3 -1.4 1.4 -9.8
0.1 0.0 0.1 0.2 0.0 0.1 0.1 0.0 0.1 0.2 0.5 0.2 0.3 0.7 0.3 0.5
-0.1 0.0 -0.1 -0.2 0.0 -0.1 -0.1 0.0 -0.1 -0.2 -0.5 -0.2 -11 8.9 -0.3 0.6
– – – – – – – – – – – 0.4 0.2 – – –
– – – – – 4.9 0.0 0.0 0.5 7.8 25 -0.6 -0.3 -0.2 0.4 –
– – – – – – -2.0 -2.0 -2.0 -2.1 22 0.0 – 0.0 -10 48
6.8 4.8 9.0 9.8 13 4.9 3.8 12 -1.5 5.6 23 47 0.4 0.3 6.2 50
-1.0 -1.4 1.5 1.9 5.7 -3.8 -2.1 6.0 -6.2 2.6 14 34 -26 -4.5 -3.0 27
-7.8 -6.3 -7.6 -8.0 -7.3 -8.7 -5.9 -6.0 -4.7 -3.0 -8.3 -13 -16 -14 -9.2 -24

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?